Arch Therapeutics Provides Year End Operational Update
November 09, 2023 06:50 ET | Arch Therapeutics, Inc.
Fiscal year-end AC5 Advanced Wound System update includes Q4 record monthly order volumes, favorable reimbursement decisions and increases in paid claims.
Research Nester Logo.jpg
Dextromethorphan Market revenue to reach USD 550 Million by 2035, says Research Nester
September 20, 2023 07:30 ET | Research Nester
New York, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The global dextromethorphan market size is slated to expand at ~4% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 550...
[Latest] Global Acute Repetitive Seizures Market Size/Share Worth USD 11.5 Billion by 2030 at a 12% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
April 21, 2023 09:30 ET | Custom Market Insights
Austin, TX, USA, April 21, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Acute Repetitive Seizures Market Size, Trends and Insights By Drug Type...
Global Acute Respiratory Distress Syndrome Market Size To Exceed USD 2137.6 Billion By 2030 | CAGR of 7.9%
April 03, 2023 12:00 ET | SPHERICAL INSIGHTS LLP
New York, United States , April 03, 2023 (GLOBE NEWSWIRE) -- The Global Acute Respiratory Distress Syndrome Market Size to grow from USD 980.4 million in 2021 to USD 2,137.6 million by 2030, at a...
Contrive Datum Insights_Logo.jpg
Electronic Health Records Software Market is anticipated to progress at a CAGR of 9.1% from 2022 to 2030, Data by Contrive Datum Insights
January 30, 2023 14:52 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The Electronic Health Records Software Market was valued at USD 14.2 Billion in 2022 and is projected to grow at a CAGR of 9.1% during the forecast...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 23, 2022 16:30 ET | Palisade Bio, Inc.
Carlsbad, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI)...